- Brightfield Transportation: in our first link to Treehugger, here is a nice article on Brightfield. What's even cooler than an electric roadster? A solar-charged electric roadster, that's what.
- Target Pharma: continues to grow its disease communities, now adding pharma giant Novartis to its TARGET-NASH community.'
- KIYATEC: Cancer innovation and hiking the Appalachian Trail have a few things in common. Learn what in the UBJ article.
- Baebies: Enjoy Baebies' newsletter for January here, including links to its knowledge center, latest research study demonstrating the feasibility of using lower sample volumes for testing coagulation markers of enzymatic functional assays on a microfluidic cartridge, and its non-profit support events. The company completed its $13M equity raise, and we were proud to be a part of it.
- Pandoodle: with Sharing Economy International Inc, announced a potential partnership agreement where SEII could acquire 51% of its stock
With a portfolio of 40 active companies, it can be hard to keep track of all their achievements. Our team of intrepid news searching scripts this month bring you:
Proterra: In addition to providing the keynote content at the VentureSouth Summit, Proterra is sending buses to San Jose airport and Greensboro NC, and showing them off in Iowa, California and Shreveport. They're driving a market continuing to grow at 28% / year; Vox's recent industry review is a great primer.
In what is rapidly becoming the Proterra and Avadim show, below are links to some of the newsworthy items for late September and October.
Proterra: after several years and much effort, here come the first two Proterra buses in Greenville. And these are now officially world-record-breaking buses; take a seat Tesla. And Proterra also announced partnerships with LG Chem, purchases by Van Hool, and more.
TiO Home announced a partnership with On Top Of The World Communities - a 3-year, 1,200-home program beginning in January.
Kwipped was featured in Total Station Markets, Chemistry World, MSN Lifestyle, the Journal Of Clinical Research Best Practices, and Irish Tech News - quite a selection. It also passed $75MM in listed assets.
Partnerships are crucial to early-stage companies to help them scale more rapidly. April saw the announcement of three example partnerships in our portfolio:
- FarmShots: announced a great partnership with Planet and John Deere
- Target Pharma: no-one does big pharma partnerships better than Target. Here is the latest announcement of Target-NASH in partnership with Allergan
- Avadim: agreed a partnership with HPSI Purchasing Services. (And continues to raise money. Our investments a < 40c / share are starting to look promising...)
Other companies launched new products and hit milestones on their own:
- Atlas Organics: launched its Dirtbags bagged compost to the market over the Easter weekend
- Booster: launched its app in the Apple Store, and started helping e-commerce sellers establish better relationships and sell more products
And Proterra just keeps on rolling:
Several exciting updates from the last few weeks.
Proterra leads the way, with coverage in Forbes - and with press on three recent deals: (1) 15 new buses funded by the San Joaquin Valley Air Pollution Control District; (2) in the Chicago Tribune of an announcement in late October about a partnership with JLL to deliver 10 Catalyst buses for a service operating between Chicago’s commuter train stations the Prudential Plaza and Aon Center, both JLL-managed properties, in Chicago; and (3) the Pioneer Valley Transit Authority in Massachusetts.
Target Pharma continues to outperform, announcing its fourth disease community in partnership with Bristol-Myers Squibb - following its earlier announcement in partnership with Intercept Pharmaceuticals.
Pharmright is accelerating nationally - demo'ing the Livi from Missouri to Maine.
And lastly Crowdr provided a sneak peak of its mobile app Booster that launches in January. See you on there!
Each month we convey some of the achievements of some of our portfolio companies. There is plenty of good news already this month, so here is an early October portfolio update.
Some really impressive milestones in several different areas. And on a lighter note, Growjourney helped Paul boast impressive rows of broccoli, kale, lettuce, chard, and bok choy in his vegetable garden for the first time. Baby kale pairs well with (VentureSouth sponsor) RJ Rockers' Bellringer. Who knew?
For the record, VentureSouth didn't invest the $637,000 listed on Crunchbase, Target doesn't have $1.4 million left to raise, and the Palmetto Angel Fund didn't invest all the $250,000 in Crowdr. Crunchbase is good, but initial SEC Form D filings and crowd-sourced data do not always tell the full story on fundraising!
Still, these were material investments for VentureSouth, and we're delighted to be partnering with such impressive companies. We wish both the best of luck.